■■■口 Prospects& Overviews J. Alcock et al 116. Peterfreund GL, vandiv inha R, Ma AJ, et al. 2012. 119. Schwiertz A, Taras D, Schafer K, Beijer s, et al. 2010. and ScFA therapies for Clostridium difficile. PLoS ONE 7: 846966 117 says35:508- 118. Ley RE, Turnbaugh PJ, Klein S, Gordon JL. 2006. Microbial ecology. human gut microbes associated with obesity. Nature 444: 1022-3 Prev Res ≤oso< Bioessays 40-949, 2014 The Authors. Bioessays published by WILEY Periodicals, Inc. 949116. Peterfreund GL, Vandivier LE, Sinha R, Marozsan AJ, et al. 2012. Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile. PLoS ONE 7: e46966. 117. Ettinger G, Burton JP, Reid G. 2013. If microbial ecosystem therapy can change your life, what’s the problem? BioEssays 35: 508–12. 118. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022–3. 119. Schwiertz A, Taras D, Scha¨ fer K, Beijer S, et al. 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18: 190–5. 120. Merlo LM, Shah NA, Li X, Blount PL, et al. 2010. A comprehensive survey of clonal diversity measures in Barrett’s esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev Res (Phila) 3: 1388–97. ....Prospects & Overviews J. Alcock et al. Bioessays 36: 940–949,
2014 The Authors. Bioessays published by WILEY Periodicals, Inc. 949 Review essays